Potent and selective inhibitor of AKT or Protein Kinase B. AKT inhibitors evolved from adenosine triphosphate (ATP). AKT inhibitors have a potential clinical application in anti-cancer ?drug development . Weak inhibitor of phosphatidylinositol 3-kinase (PI3-K) (IC= 83 M). Has been shown to inhibit the growth of the following cancer cell lines: HeLa (IC= 2.5 M), HT-29 (IC= 10 M), MCF-7 (IC= 1.2 M), and PC-3 (IC= 2.0 M).
BIOLEAF熱搜 BIOLEAF試劑盒 BIOLEAF ELISA BIOLEAF試劑 BIOLEAF品牌 BIOLEAF抗體 BIOLEAF耗材 BIOLEAF小儀器
sitemap 細(xì)胞庫(kù)查詢 危險(xiǎn)品圖標(biāo) 本公司網(wǎng)站所展示銷售的產(chǎn)品僅供科研！
滬公網(wǎng)安備 31011202007338號(hào)
<span id="wnywp"></span>
